Securing financing is never easy, but can be made more transparent. Swandbridge Capital will share with you what they look for when investing in Biotech and Medtech companies.
Swanbridge Capital invests in high potential companies in the Life Sciences. We aim to build a balanced portfolio that is mixed in terms of technology, risk profile and exit horizon. Where our technological focus is broad, we solely invest in companies in very early stage of development. By securing strong shareholder positions we are committed to actively collaborate with our portfolio companies.

Early stage investments usually require more than just a financial investment. Our involvement goes beyond that by actively supporting our portfolio companies. Swanbridge Capital is in the position to provide the knowledge and network that young companies require in order to bring their technology and company to the next phase.

About Swanbridge Capital
Swanbridge Capital is a Rotterdam based venture capital fund that actively invests in young, high potential companies in the life sciences. We focus on companies that are in very early stage in their development of therapeutics, diagnostics and medical devices. Our team is committed to actively support our portfolio companies in their quest for success.

February 20, 2020